MDPI and ACS Style
Elgazzar, D.; Aboubakr, M.; Bayoumi, H.; Ibrahim, A.N.; Sorour, S.M.; El-Hewaity, M.; Elsayed, A.M.; Shehata, S.A.; Bayoumi, K.A.; Alsieni, M.;
et al. Tigecycline and Gentamicin-Combined Treatment Enhances Renal Damage: Oxidative Stress, Inflammatory Reaction, and Apoptosis Interplay. Pharmaceuticals 2022, 15, 736.
https://doi.org/10.3390/ph15060736
AMA Style
Elgazzar D, Aboubakr M, Bayoumi H, Ibrahim AN, Sorour SM, El-Hewaity M, Elsayed AM, Shehata SA, Bayoumi KA, Alsieni M,
et al. Tigecycline and Gentamicin-Combined Treatment Enhances Renal Damage: Oxidative Stress, Inflammatory Reaction, and Apoptosis Interplay. Pharmaceuticals. 2022; 15(6):736.
https://doi.org/10.3390/ph15060736
Chicago/Turabian Style
Elgazzar, Dina, Mohamed Aboubakr, Heba Bayoumi, Amany N. Ibrahim, Safwa M. Sorour, Mohamed El-Hewaity, Abulmaaty M. Elsayed, Shaimaa A. Shehata, Khaled A. Bayoumi, Mohammed Alsieni,
and et al. 2022. "Tigecycline and Gentamicin-Combined Treatment Enhances Renal Damage: Oxidative Stress, Inflammatory Reaction, and Apoptosis Interplay" Pharmaceuticals 15, no. 6: 736.
https://doi.org/10.3390/ph15060736